pubmed-article:11115826 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0008377 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0005388 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0567416 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0015684 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0005390 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:11115826 | lifeskim:mentions | umls-concept:C0301869 | lld:lifeskim |
pubmed-article:11115826 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:11115826 | pubmed:dateCreated | 2001-1-30 | lld:pubmed |
pubmed-article:11115826 | pubmed:abstractText | Cholesterol gall stones are a frequent disease for which at present surgery is the usual therapy. Despite the importance of bile acids it has become evident that phospholipids are the main cholesterol solubilisers in bile. Even phospholipid components, such as fatty acids, have anticrystallising activity. | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:language | eng | lld:pubmed |
pubmed-article:11115826 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11115826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11115826 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11115826 | pubmed:month | Jan | lld:pubmed |
pubmed-article:11115826 | pubmed:issn | 0017-5749 | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:RosenbergRR | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:GilatTT | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:SomjenG JGJ | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:MazurYY | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:KonikoffFF | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:HalpernZZ | lld:pubmed |
pubmed-article:11115826 | pubmed:author | pubmed-author:Leikin-Frenke... | lld:pubmed |
pubmed-article:11115826 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11115826 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:11115826 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11115826 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11115826 | pubmed:pagination | 75-9 | lld:pubmed |
pubmed-article:11115826 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:meshHeading | pubmed-meshheading:11115826... | lld:pubmed |
pubmed-article:11115826 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11115826 | pubmed:articleTitle | Fatty acid bile acid conjugates (FABACs)--new molecules for the prevention of cholesterol crystallisation in bile. | lld:pubmed |
pubmed-article:11115826 | pubmed:affiliation | Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv 64239, Israel and Tel-Aviv University. tuvgilat@netvision.net.il | lld:pubmed |
pubmed-article:11115826 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11115826 | lld:pubmed |